The industry analysis specialist, has released its
latest report,
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape Philippines.
The report is an essential source of information and analysis regarding the
healthcare, regulatory and reimbursement landscape in the Philippines. It
identifies key trends in the healthcare market and provides insights into the
demographic, regulatory, reimbursement landscape and healthcare infrastructure
in the country. Most importantly, the report provides valuable insights into the
trends and segmentation of the pharmaceutical and medical device markets. This
resource has been produced using data and information from proprietary
databases, secondary research, and in-house analysis by GlobalDatas team of
industry experts.
The population of the Philippines amounted to approximately 99.2 million
in 2013, making it the 12th most populated country in the world. Population
growth has primarily been due to a high birth rate and rising life expectancy.
An increased elderly population is however a matter of concern for policy
planners. The value of the pharmaceutical market in the country amounted to $4.3
billion in 2013, and it is expected to increase at a CAGR of 9.4% to reach
approximately $8 billion in 2020.
The positive trend in the healthcare market of the Philippines can be attributed primarily to the following factors:
Generic substitution in both the public and private sectors, which has been a driver for the manufacture of generic drugs
Increased expenditure on medicines by Local Government Units (LGUs)
Government initiatives for the prevention and management of chronic diseases
An improved and updated regulatory environment
Scope
This report provides information on the healthcare, regulatory, and reimbursement landscape in the Philippines, including the following:
An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
Profiles and SWOT analyses for major players in the pharmaceutical market (United Laboratories, Pfizer, GlaxoSmithKline, Novartis, Merck)
An insightful review of the reimbursement and regulatory landscape, including details of the healthcare reimbursement process, regulatory agencies, and approval processes for new drugs and medical devices
Detailed analysis of the political and economic environment, covering economic indicators, demographics, healthcare infrastructure, and healthcare expenditure
An overview of the opportunities for and challenges facing growth in the healthcare market
Reasons To Buy
This report will enhance your decision-making capability by allowing you to:
Develop business strategies based on a sound understanding of the trends shaping and driving the healthcare market in the Philippines
Generate revenue based upon knowledge of key trends, reimbursement and regulatory policies, pharmaceutical market segments, and the companies likely to impact the healthcare market in the future
Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
Organize sales and marketing efforts by identifying the market categories and segments that present the greatest opportunities for consolidation, investment, and strategic partnership
Identify, understand, and capitalize upon the opportunities and challenges in the Philippines healthcare market
The positive trend in the healthcare market of the Philippines can be attributed primarily to the following factors:
Generic substitution in both the public and private sectors, which has been a driver for the manufacture of generic drugs
Increased expenditure on medicines by Local Government Units (LGUs)
Government initiatives for the prevention and management of chronic diseases
An improved and updated regulatory environment
Scope
This report provides information on the healthcare, regulatory, and reimbursement landscape in the Philippines, including the following:
An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
Profiles and SWOT analyses for major players in the pharmaceutical market (United Laboratories, Pfizer, GlaxoSmithKline, Novartis, Merck)
An insightful review of the reimbursement and regulatory landscape, including details of the healthcare reimbursement process, regulatory agencies, and approval processes for new drugs and medical devices
Detailed analysis of the political and economic environment, covering economic indicators, demographics, healthcare infrastructure, and healthcare expenditure
An overview of the opportunities for and challenges facing growth in the healthcare market
Reasons To Buy
This report will enhance your decision-making capability by allowing you to:
Develop business strategies based on a sound understanding of the trends shaping and driving the healthcare market in the Philippines
Generate revenue based upon knowledge of key trends, reimbursement and regulatory policies, pharmaceutical market segments, and the companies likely to impact the healthcare market in the future
Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
Organize sales and marketing efforts by identifying the market categories and segments that present the greatest opportunities for consolidation, investment, and strategic partnership
Identify, understand, and capitalize upon the opportunities and challenges in the Philippines healthcare market
Very knowledgable. I'd suggest you host you site on your own domain name , so that people would be more easier to remember you blog address
ReplyDeleteAutomotive Camera Market Research & Analysis Report – Report Banana